BioVie Inc [NASDAQ: BIVI] closed the trading session at $3.11.
The stocks have a year to date performance of -75.32 percent and weekly performance of -2.20 percent. The stock has been moved at -32.39 percent over the last six months. The stock has performed 21.01 percent around the most recent 30 days and changed -3.72 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 5.48M shares, BIVI reached to a volume of 3159136 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about BioVie Inc [BIVI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIVI shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIVI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for BioVie Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 22, 2022. While these analysts kept the previous recommendation, B. Riley Securities raised their target price to Buy. The new note on the price target was released on January 15, 2021, representing the official price target for BioVie Inc stock.
The Average True Range (ATR) for BioVie Inc is set at 0.49 The Price to Book ratio for the last quarter was 1.76, with the Price to Cash per share for the same quarter was set at 1.13.
BIVI stock trade performance evaluation
BioVie Inc [BIVI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.20. With this latest performance, BIVI shares gained by 21.01% in over the last four-week period, additionally sinking by -32.39% over the last 6 months – not to mention a drop of -92.83% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BIVI stock in for the last two-week period is set at 56.34, with the RSI for the last a single of trading hit 53.80, and the three-weeks RSI is set at 55.87 for BioVie Inc [BIVI]. The present Moving Average for the last 50 days of trading for this stock 2.28, while it was recorded at 3.32 for the last single week of trading, and 4.60 for the last 200 days.
BioVie Inc [BIVI]: An insightful look at the core fundamentals
BioVie Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.95 and a Current Ratio set at 2.95.
BioVie Inc [BIVI]: Institutional Ownership
There are presently around $9.99%, or 11.57%% of BIVI stock, in the hands of institutional investors. The top three institutional holders of BIVI stocks are: ALTIUM CAPITAL MANAGEMENT LP with ownership of 1.98 million shares, which is approximately 4.4248%. SABBY MANAGEMENT, LLC, holding 0.73 million shares of the stock with an approximate value of $$0.29 million in BIVI stocks shares; and SABBY MANAGEMENT, LLC, currently with $$0.23 million in BIVI stock with ownership which is approximately 1.2687%.
